Initial trials demonstrate that this peptide – a dual agonist of gut hormone and glucose-dependent insulinotropic polypeptide receptors – presents a significant improvement in weight loss programs . Beyond existing therapies, this dual-action compound appears to influence hunger and metabolic utilization through separate pathways . Although mo… Read More